Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy. by Harari, PM et al.
UC Irvine
UC Irvine Previously Published Works
Title
Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy.
Permalink
https://escholarship.org/uc/item/1wt2d2kq
Journal
International journal of radiation oncology, biology, physics, 19(1)
ISSN
0360-3016
Authors
Harari, PM
Fuller, DJ
Carper, SW
et al.
Publication Date
1990-07-01
DOI
10.1016/0360-3016(90)90139-b
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Inl. J. Radialron Oncology Bud Phys.. Vol. 19, pp. X9-96 
Printed in the U.S.A. All rights reserved. 
036s3016/90 $3.00 + .OO 
Copyright 0 1990 Pergamon PIGS plc 
??ASTRO 1989 Resident Essay Award 
POLYAMINE BIOSYNTHESIS INHIBITORS COMBINED WITH SYSTEMIC 
HYPERTHERMIA IN CANCER THERAPY 
PAUL M. HARARI, M.D., DAVID J. M. FULLER, PH.D., STEPHEN W. CARPER, PH.D., 
MARILYN K. CROGHAN, M.D., FRANK L. MEYSKENS JR., M.D., 
DAVID S. SHIMM, M.D. AND EUGENE W. GERNER, PH.D. 
The University of Arizona Cancer Center, Department of Radiation Oncology and 
Department of Medicine, Section of Medical Oncology, Tucson, AZ 85724 
A Phase I clinical trial has been initiated at the University of Arizona Cancer Center which combines escalating 
oral doses of the polyamine biosynthesis inhibitor adifluoromethylomithine (DFMO), with systemic hyperthermia 
(--4lS”C) in the treatment of metastatic melanoma. The rationale for the combination of hyperthermia and poly- 
amine biosynthesis inhibitors in the treatment of human cancers includes studies which show that depletion of 
endogenous polyamines, as a result of treatment with DFMO, sensitizes both rodent and human tumor cells to the 
cytotoxic effects of hyperthermia. Heat shock induces the first enzyme in polyamine catabolism, spermidine/ 
spermine N’-acetyltransferase (N’SAT). The consequently acetylated forms of spermidine and spermine are then 
constitutively oxidized by the enzyme polyamine oxidase (PAO). Both CHO and human A549 lung cancer cells 
exhibit heat-inducible polyamine acetylation, display potent heat sensitization after polyamine depletion, and ul- 
timately reveal prolonged expression of thermotolerance. Conversely, HeLa cells do not demonstrate heat-inducible 
polyamine catabolism, are not sensitized to heat with DFMO, and display more rapid kinetics of thermotolerance 
decay. These laboratory studies suggest that enhancement of the cytotoxic action of hyperthermia by DFMO occurs 
as a consequence of the inhibition of polyamine catabolism, a heat-inducible process that affords some form of 
protection to cells undergoing heat stress. Human melanoma cultures demonstrate heat-inducible polyamine ca- 
tabolism and are sensitized to hyperthermic cytotoxicity by DFMO. To date, 24 systemic hyperthermia treatments 
have been delivered to nine patients with metastatic melanoma in conjunction with oral DFMO under this Phase 
I clinical trial. 
Systemic hyperthermia, Polyamines, DFMO, Melanoma. 
INTRODUCTION 
The naturally occurring polyamines play an essential role 
in the growth, proliferation and differentiation of mam- 
malian cells ( 16, 24). A simplified schematic of polyamine 
metabolism is depicted in Figure 1. Manipulation of 
polyamine metabolism through the use of enzyme inhib- 
itors has been under investigation for its potential utility 
in anticancer therapies. DFMO, the irreversible inhibitor 
of ornithine decarboxylase (ODC), the first ehzyme in 
polyamine biosynthesis, has been studied for its antipro- 
liferative activity alone, and in combination with a variety 
of anticancer agents ( 1,2,4, 14, 16,22). DFMO has further 
been implicated as an antimetastatic agent based on its 
capacity to inhibit pulmonary metastases in mice (23). 
Recently, a specific, irreversible inhibitor of polyamine 
catabolism has been synthesized (polyamine oxidase in- 
hibitor [PAOI], MDL-72.521), and thus the physiolog- 
ical significance of this pathway is under evaluation as 
well (3). 
The clinical use of hyperthermia to treat human cancer 
has advanced markedly in recent years due to improve- 
ments in hyperthermia technology, and due to progress 
in our understanding of the mechanisms of synergy be- 
tween heat and other anticancer agents. The relationship 
between heat sensitivity and polyamine metabolism has 
been a focus of our laboratory, with particular regard to 
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Fig. 1. Schematic of polyamine metabolism citing location of 
synthesis inhibition by cYdifluoromethlyomithine (DFMO), and 
catabolism inhibition by polyamine oxidase inhibitor (PAOI). 
methods of enhancing hyperthermic cytotoxicity for ther- 
apeutic gain. It is known that depletion of endogenous 
polyamine pools, via synthesis blockade with DFMO, 
renders cells more sensitive to subsequent heat stress (7, 
8). Further, pathways of polyamine catabolism are affected 
by thermal stress and appear to influence ultimate cell 
viability responses under certain conditions (9). 
The present study was conducted to further establish 
the rationale for combining polyamine biosynthesis in- 
hibitors with hyperthermia in the treatment of human 
cancers. Experimental results suggest that the mechanism 
of enhanced cytotoxicity due to DFMO/hyperthermia 
combinations may involve the inhibition of polyamine 
catabolism, a finding which has important implications 
for new inhibitor development. Studies with several hu- 
man tumor and rodent cell lines suggest that the ability 
of heat shock to induce polyamine acetylation may be a 
useful marker to predict whether polyamine synthesis in- 
hibitors will potentiate hyperthermia-induced cell killing. 
Finally, a Phase I clinical trial combining DFMO and 
systemic hyperthermia is introduced for the treatment of 
patients with metastatic melanoma. 
METHODS AND MATERIALS 
Cell culture 
All cell cultures were maintained as monolayer cultures 
in McCoy’s 5A medium supplemented with 10% fetal bo- 
vine serum plus 1% penicillin-streptomycin solution.* 
Cultures were maintained at 37°C in humidified incu- 
bators with 5% CO2 :95% air. The following cell lines were 
studied with approximate doubling times indicated; CHO 
16- 18 hr, A549 18-20 hr, Hela 22-24 hr. All experiments 
were initiated with exponentially growing cultures. 
July 1990, Volume 19. Number 1 
Hyperthermia treatments 
All heat shock treatments were performed by sealing 
T-25 or T-75 flasks+ and immersing them in a precision 
temperature-controlled circulating water bath (*O. 1 “C) 
for treatment times indicated in text. 
Polyamine analysis 
Separation of the natural polyamines and their mono- 
acetyl derivatives was achieved by reverse-phase high- 
performance liquid chromatography (HPLC) using the 
method of Seiler and Knodgen ( 19). All representative 
HPLC experiments were replicated a minimum of three 
times. 
Glutathione assay 
Glutathione levels were measured by the method of 
Tietze (25) 6 hr following removal from 43°C heat stress. 
Cells were harvested, washed twice and resuspended at a 
concentration of 6 X lo6 cells/ml. After deproteinization 
with 0.6% sulfosalicylic acid and centrifugation at O”C, 
the supernatant was assayed for glutathione content by 
spectrophotometry at 4 12 nm after addition of dithioni- 
trobenzoic acid in the presence of glutathione reductase 
and NADPH. Values of glutathione in untreated CHO 
cultures ranged from 1.9 - 2.6 pg/ lo6 cells. 
Spermidine N1 -acetyltransferase (N1 -SA T) assay 
Enzyme activity was measured 6 hr following heat stress 
by a method adapted from Libby ( 11) and Matsui et al. 
(12). Cells were resuspended in 50 mM Tris pH 7.5, 2.5 
mM DTT and 0.1 mM EDTA at a concentration of 4 
X lo7 cells/ml, Each assay contained 3 mM spermidine, 
50 mM Tris pH 7.8 and 8 clM-[l-‘4C] Acetyl CoA in a 
total volume of 100 ~1. Activity was measured by the in- 
corporation of 14C label into spermidine from 14C-Acetyl 
CoA and expressed as units per lo6 cells, where 1 unit 
represents production of 1 pmol of N’-acetylspermidine 
per minute. 
Survival determinations 
After heat shock or chemical treatments, known num- 
bers of single cells were plated into 60 mm petri dishes in 
5 ml of growth medium and incubated for 7-10 days. 
Colonies were stained with crystal violet and counted 
manually. All experimental groups were plated in tripli- 
cate. Plating efficiency for untreated controls ranged from 
80-95%. Mean survival values were determined and plot- 
ted + standard error of the mean. 
Systemic hyperthermia 
The CDRH Helix used for systemic hyperthermia 
treatments and the methods of patient preparation for 
whole body heating are previously described (10,20,2 1). 
* All from Grand Island Biological Co., Grand Island, NY. + Parafilm “M”, American Can Co., Greenwich, CT. 
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Drugs and drug treatments 
The following chemicals 
S,R sulfoximine (BSO), 
were purchased: buthionine 
dithiobis-nitrobenzoic acid 
(DTNB) sulfosalicylic acid,f [ l-‘4C]-Acetyl-CoA.§ DFMO 
and the polyamine oxidase inhibitor, MDL-72.52 1 were 
gifts.** 
All treatments with the PA0 inhibitors were carried 
out at a concentration of 25 PM added directly to culture 
medium 2-4 hr prior to subsequent heat or drug treat- 
ments. For colony formation experiments, the PA0 in- 
hibitor (25 PM) was present in dishes throughout the col- 
ony forming period. Buthionine S,R sulfoximine (10 mM) 
was added to cultures 24 hr prior to heat shock, but was 
not present during the colony forming interval. DFMO 
treatments were generally carried out at 5 mM concen- 
trations with 8 hr exposure times 36 hr prior to survival 
experiments, and 48 hr continuously prior to enzyme 
studies. 
RESULTS 
Heat shock-induced polyamine acetylation 
The effects of heat shock on polyamine oxidation were 
studied using a recently synthesized inhibitor of PAO, 
MDL-72.52 1. This specific, irreversible inhibitor of PA0 
blocks the intracellular oxidation of N’-acetylspermidine 
and subsequent formation of putrescine, 3-acetamido- 
propanal and hydrogen peroxide (3). Cultures receiving 
a 43°C X 90 minute heat shock, and then incubated at 
37°C displayed elevated putrescine levels during the 6 hr 
interval immediately following hyperthermic stress (Fig. 
2). This rise in putrescine was completely blocked when 
cultures were treated with the PA0 inhibitor. Further, 
N’-acetylspermidine levels increased in heat shocked cul- 
tures from undetectable levels to 1.5-2.0 nmol/mg protein 
in the presence of the PA0 inhibitor. Spermine contents 
did not vary substantially during these treatments, while 
spermidine levels decreased slightly in heat shocked cul- 
tures treated with the PA0 inhibitor reflecting the for- 
mation of N’-acetylspermidine. These results demonstrate 
that the transient increase in putrescine content in cultures 
following heat stress is due to acetylation and subsequent 
oxidation of spermidine. 
Polyamine oxidation afects glutathione pools 
The oxidation of N’-acetylspermidine by PA0 results 
in the formation of putrescine, 3-acetamidopropanal (a 
reactive aldehyde), and hydrogen peroxide. Both of these 
latter two species are potentially cytotoxic and their de- 
toxification may involve the cellular non-protein sulthy- 
dryl, glutathione. Known detoxification reactions involv- 
ing glutathione include the reduction of hydrogen per- 
oxide to HZ0 producing GSSG (the oxidized form of 
I 
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Fig. 2. Effects of heat shock on polyamine acetylation and oxi- 
dation. Log phase CHO cultures were heat shocked at 43°C for 
90 min in the presence (m) or absence (0) of the PA0 inhibitor 
(25 PM). Control cultures at 37°C plus (0) or minus (0) the 
PA0 inhibitor were also analyzed. Polyamine analysis was car- 
ried out via HPLC at times indicated after heat shock. 
glutathione), and conjugation of glutathione to reactive 
moieties followed by their excretion from the cell (13). 
To determine whether glutathione was involved in any 
aspect of polyamine oxidation, levels of glutathione were 
measured after heat stress (Fig. 3). 
Glutathione content was found to decrease in a manner 
dependent on both the time at euthermic temperature 
Hours Aftef Heat shock Minutes at 43% 
Fig. 3. Effects of heat shock on glutathione content. Log phase 
CHO cultures were heat shocked at 43°C for 90 min in the 
presence (0) or absence (0) of the PA0 inhibitor and assayed 
for glutathione content at the indicated times after heat (left 
panel). Cultures that were heated at 43°C for various times were 
assayed for glutathione content at 6 hr after heat shock (right 
panel). 
* Sigma Chemical Co. 
5 New England Nuclear. 
** Merrell Dow Laboratories, Cincinnati, OH. 
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after heat shock, and the duration of the heat stress. Levels 
of glutathione decreased by 65% at 6 hr after cultures 
were returned to 37°C following exposure to 43°C for 90 
minutes. Treatment of cultures with the PA0 inhibitor 
partially inhibited this decrease in glutathione. The level 
of glutathione 6 hr after 43°C heat stress was also depen- 
dent on the duration of the hyperthermic treatment and 
decreases could be measured for exposures as short as 30 
minutes. For all durations studied, the PA0 inhibitor af- 
forded a partial reduction in the observed decrease in glu- 
tathione levels. 
Polyamine oxidation and cell viability 
The PA0 alone has no effect on the 43°C survival re- 
sponse of Chinese hamster cells as measured by colony 
formation (Fig. 4). However, a small protective effect on 
cell survival was observed in heat shocked cultures which 
were first depleted of cellular glutathione with the gluta- 
thione synthesis inhibitor, buthionine sulfoximine. This 
latter treatment, which is known to sensitize mammalian 
cells to the cytotoxic effects of heat (15) reduced gluta- 
thione levels by 70% from control values. This observation 
suggests that heat-induced endogenous polyamine oxi- 
dation can affect viability responses in glutathione de- 
pleted cultures, although polyamine oxidation is appar- 
ently not the sole participant in this hyperthermic toxicity. 
100, 
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Fig. 4. Effects of PA0 inhibition on survival of glutathione de- 
pleted cells. Log phase CHO cultures were plated for colony 
formation after heat shock at 43”C, preceded by various pre- 
treatments. BSO (10 mM) was added 24 hr prior to heat shock 
and PA0 inhibitor (25 PM) was added 4 hr prior to heat shock 
and remained present throughout colony formation. 
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Fig. 5. HeLa cell colony survival at 43°C in control cultures 
(O), and in cultures treated with 5 mM DFMO for 8 hr (0). 
DFMO was then removed and cultures were incubated in fresh 
medium without drug for 36 hr prior to heat stress. 
Polyamine acetylation and DFMO-induced heat 
sensitization 
Figure 5 describes the 43°C survival response of HeLa 
cells (human cervix cancer) after polyamine depletion with 
DFMO. No appreciable difference in survival is observed 
comparing polyamine depleted cultures with controls. 
This is in distinct contrast to the results in CHO cultures 
(rodent line), where a 2 log sensitization to heat by DFMO 
is observed under identical conditions (7, 8). These find- 
ings have led us to further investigate the cell line speci- 
ficity of heat shock and polyamine responses, with par- 
ticular regard to the inducibility of polyamine acetylation 
by heat, and the sensitization to heat stress by polyamine 
depletion. 
Table 1 outlines the correlation of heat-inducibility of 
polyamine acetylation (N’-SAT induction) and heat sen- 
sitization by DFMO in one rodent (CHO) and two human 
(A549 and HeLa) cell lines. The CHO and A549 cell lines 
demonstrate heat-inducible polyamine acetylation (7- 10 
fold increase in N’-SAT activity after heat stress), and this 
induction can be inhibited by pretreatment with DFMO. 
These cell lines also display significant heat sensitization 
(l-2 logs) after polyamine depletion with DFMO. The 
HeLa cells show no measurable induction of polyamine 
acetylation after heat stress, and exhibit virtually super- 
imposable survival responses at 43°C despite polyamine 
depletion. These data suggest a potential relationship be- 
tween heat-inducibility of polyamine catabolism and heat 
sensitization by DFMO (see Discussion). 
Thermotolerance decay 
An appreciation of the expression and decay kinetics 
of thermotolerance is critical to the successful implemen- 
tation of clinical hyperthexmia programs (6). We have 
examined the expression and decay of thermotolerance 
in rodent and human cell lines using split heat dose ex- 
periments as depicted in Figure 6. While only minor vari- 
ations in the time course for development of thermotol- 
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Table 1. Comparison of the DFMO-dependent heat-inducibility of Nr-SAT activity and sensitization 
to hyperthermia-induced cytotoxicity by DFMO in cell cultures 
Cell 
line 
CHO 
A549 
HS 
(temp. X time-min) 
43” x 90 
45” x 30 
45” x 20 
45” x 40 
N’-SAT activity (units/ 1 O6 cells) 
+HS* 
-HS -DFMO +DFMO 
2.1 + 0.1 21.7 + 1.3 1.4 + 0.2 
2.4 + 0.3 16.4 * 1.7 4.2 k 0.3 
Sensitization by DFMO 
(% survival)* 
-DFMO +DFMO 
2.96 + 0.34 0.012 + 0.0012 
0.11 + 0.03 0.003 ?I 0.001 
0.08 + 0.01 0.004 + 0.0001 
HeLa 43” x 90 0.5 + 0.1 0.5 + 0.1 - 5.34 + 1.60 5.43 + 2.15 
* N’-SAT activity was measured at 6 hr after these heat shocks. For survival experiments, cells were treated with DFMO (5 mM) 
for 8 hr and then incubated at 37°C for 36 hr prior to HS; for enzyme studies, the cultures were treated with DFMO (5 mM) 
continuously for 48 hr prior to HS. 
HS = Heat shock; -HS = Non-heat shocked control. 
erance are seen among the three cell lines examined, the 
decay pattern is markedly prolonged for CHO and A549 
cells as compared with HeLa cells. Even at 60 hr after the 
initial heat stress, CHO and A549 cells are on the order 
of 2 logs more resistant to subsequent heating than con- 
trols. HeLa cells, on the other hand, demonstrate complete 
thermotolerance decay by 50 hr. The potential relation- 
ship between heat-inducibility of polyamine acetylation, 
and the maintenance of thermotolerance will be further 
discussed. 
Hyperthermia/DFMO efects on human tumors 
Human tumor cell clonogenic assays have been used 
to screen for the activity of anticancer agents toward a 
particular tumor. Table 2 depicts the response of human 
melanoma tumor cells, obtained from patient biopsy, to 
a battery of cytotoxic agents (Vinzolidine), biologic re- 
sponse modifiers (MTP, a-IFN, -y-IFN, Interleukin-2), hy- 
perthermia and hyperthermia plus DFMO combinations. 
Of the agents tested, DFMO followed by 42°C heating 
100 1 
0 10 20 30 40 50 60 70 80 
Hours Between Two Heat Doses 
Fig. 6. Thermotolerance decay kinetics in CHO (O), HeLa (0) 
and A549 (0) cells measuring colony survival via split heat dose 
experiments. Heating sequences were; CHO (45°C X 10 mitt, 
then 20 min), HeLa (43°C X 60 mitt, then 120 min), A549 
(45°C X 10 min, then 30 min). 
afforded the largest cytotoxic effect as measured by colony 
formation. This combination resulted in more than a 50% 
reduction in colony forming ability under all conditions 
tested. In this assay system, such reductions in colony 
formation have been associated with a 20-30% rate of 
clinical tumor response (18). These results show that for 
this patient sample, the combination of 42°C hyperther- 
mia and DIM0 is the most effective of the agents tested 
in reducing melanoma cell colony formation. 
Systemic hyperthermia 
Figures 7 and 8 depict, respectively, the CDRH Helix 
used for induction of systemic hyperthermia, and a rep- 
resentative time versus temperature plot for a patient un- 
dergoing whole body hyperthermia. Previous and in pro- 
gress publications describe in detail the hyperthermia 
physics and technology involved in the CDRH Helix for 
regional and systemic hyperthermia ( 10,20,2 1). However, 
one important feature of this heating method deserves 
highlighting in Figure 8. Note that the time to achieve 
“therapeutic” temperatures (defined here as 24 1.5 “C) is 
on the order of 25 minutes. This relatively rapid rate of 
core heating is critical to the avoidance of thermotolerance 
development which has presented a major biological 
stumbling block to the use of systemic hyperthermia in 
cancer therapy. 
DISCUSSION 
This study investigates the biological rationale for 
combining systemic hyperthermia with polyamine bio- 
synthesis inhibition in the treatment of human cancer. 
Figures 2-4 describe phenomena related to the heat stress- 
induced catabolism (acetylation and oxidation) of endog- 
enous polyamines. The finding that heat shock stimulates 
acetylation of spermidine (Fig. 2), via activation of N’- 
SAT (9), led us to investigate the potential physiological 
consequences of polyamine catabolism. No biological 
purpose has yet been ascribed to this metabolic pathway. 
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Table 2. Survival, as measured by colony forming ability, of human melanoma tumor cells isolated from a tumor biopsy and 
grown in soft agar cultures in response to treatments with various anticancer agents 
Agent tested Duration Concentration Survival (%)* 
Vinzolidine I hr 1 a/ml 
Liposomal MTP 1 hr 40 &ml 
a-IFN Continuous 4 ng/ml 
y-IFN Continuous 1000 units 
Interleukin-2 Continuous 1000 units 
42°C 
DFMO 
DFMO --t 42°C 
I hr 
3 hr 
DFMO 3 hr, Wait 48 hr, then 42°C 
0.5 mM 
5mM 
0.5 mM 
5mM 
* Untreated colony forming efficiency was 0.13%. 
The constitutive oxidation of acetylated spermidine by 
PA0 liberates both acetamidopropanal (a reactive alde- 
hyde) and H202. We initially hypothesized that these re- 
active oxygen species, generated from endogenous poly- 
amine oxidation after heat stress, might be responsible in 
part for hyperthermic cytotoxicity. This hypothesis was 
tested by using the inhibitor of PA0 to study cell survival 
responses in control cultures and in cultures depleted of 
endogenous glutathione which is known to function in 
the neutralization of free H202 (13). These studies revealed 
that heat stress-induced polyamine catabolism leads to a 
reduction in cellular glutathione levels (Fig. 3). However, 
only a partial block of the glutathione reduction after heat 
shock is achieved with inhibition of polyamine oxidation 
suggesting that other endogenous defense systems, such 
as catalase, superoxide dismutase or nucleophilic protein 
moieties, may provide a majority influence in detoxifying 
these oxygen species. 
Inhibition of polyamine oxidation has no discernible 
effect on cell survival responses unless cultures are pre- 
Fig. 7. CDRH Helix with model patient in position for systemic 
hyperthermia treatment. 
98.00 Z!I 18.07 
112.25 f 13.82 
76.02 + 12.21 
72.46 + 3.81 
86.71 f 11.58 
84.14 f 10.12 
36.43 + 5.00 
66.12 f 4.25 
31.48 f 2.17 
44.25 + 1.22 
viously depleted of endogenous glutathione pools (Fig. 4). 
Such results suggest that the byproducts of polyamine ox- 
idation are not normally toxic to cells undergoing hyper- 
thermic stress. In fact, since N’-SAT is heat-inducible in 
the presence of polyamines, and polyamine depletion in- 
creases heat sensitivity, we infer that polyamine acetyla- 
tion may afford some protection against the toxic effects 
of heat stress. This conclusion leads to the hypothesis that 
inhibitors of polyamine acetylation may also serve as po- 
tent sensitizers of heat shock responses. 
Not all cell lines studied were found to exhibit thermal 
sensitization after polyamine depletion with DFMO (Fig. 
5). Such exceptions led us to reinvestigate three distinct 
phenomena regarding the interactions of polyamine me- 
tabolism and hyperthermia across several cell lines; spe- 
cifically, the heat-inducibility of polyamine acetylation 
(Table l), the heat sensitization afforded by polyamine 
depletion (Table 1 ), and finally the expression and sub- 
sequent decay of thermotolerance using split heat dose 
experiments (Fig. 6). A striking pattern emerges revealing 
42 
41 
40 
39 
38 
- VAGINAL - __.____._ RE(..AL 
36 -I 
0 20 40 60 80 100 
Treatment Time (minutes) 
Fig. 8. Temperature versus time plot of oral, vaginal and rectal 
temperatures in a patient with metastatic melanoma receiving 
systemic hyperthermia in conjunction with oral DFMO. 
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that cells exhibiting heat-inducible polyamine acetylation 
are sensitized to heat by DFMO, and ultimately display 
a prolonged decay pattern of thermotolerance (CHO and 
A549). Conversely, HeLa cells display non heat-inducible 
polyamine acetylation, are not sensitized to heat with 
DFMO, and demonstrate more rapid kinetics of ther- 
motolerance decay. 
Interpretation of such correlative observations requires 
reexamination of the overall scheme of polyamine me- 
tabolism (Fig. 1). The induction of N’-SAT by heat stress 
appears to require spermidine and putrescine as evidenced 
by abolishment of this induction in cultures depleted of 
spermidine and putrescine by DFMO (Table 1). The find- 
ing that HeLa cells do not display heat-inducible poly- 
amine acetylation may merely reflect a lesser availability 
of cycling spermidine and putrescine pools. A putative 
function of endogenous polyamines is that their linear 
structure and protonated state at physiological pH affords 
general buffering and stabilizing functions toward nega- 
tively charged proteins and DNA molecules within the 
cell (24). Cell lines with large pools of unconjugated or 
“bioavailable” polyamines might therefore be more sus- 
ceptible to polyamine depletion by DFMO and subse- 
quent sensitization by hyperthermic stress. HeLa cells may 
more effectively compartmentalize or sequester their in- 
tracellular polyamines in association with critical targets, 
thus the absence of heat sensitization when cycling pools 
are interrupted by DFMO. 
The concept of compartmentalization of intracellular 
polyamines was originally advanced by Dewey (5) and 
might be expanded to evaluate the thermotolerance decay 
patterns depicted in Figure 6. If cycling or bioavailable 
pools of polyamines can provide molecular stabilization 
functions after heat stress, their presence may affect pat- 
terns of thermotolerance decay. Recent work in the A549 
cell line has demonstrated that the decay of thermotol- 
erance can be rapidly accelerated by prior polyamine de- 
pletion with DFMO ( 17). Future studies are underway to 
clarify the role of endogenous polyamines in thermotol- 
erance responses. 
The potency of hyperthermic enhancement via poly- 
amine depletion in vitro has encouraged its evaluation in 
the clinic. A Phase I trial has therefore been initiated at 
the University of Arizona Cancer Center using oral 
DFMO in conjunction with systemic hyperthermia in the 
treatment of metastatic melanoma. Melanoma cultures 
from human tumor biopsies demonstrate potent heat 
sensitization following polyamine depletion by DFMO. 
Previous clinical and in vitro studies have indicated mod- 
est activity of DFMO alone (1, 13) and in combination 
with other anticancer agents (2,4,22). The data presented 
in this paper would suggest that further therapeutic gains 
might be achieved by combining the cytostatic effects of 
polyamine biosynthesis inhibition (DFMO), with the tu- 
moricidal activity of hyperthermia. 
We have confirmed in vitro that hyperthermic en- 
hancement with DFMO can be achieved at 42°C (un- 
published results-D. J. M. Fuller, May 1986) which rep- 
resents a more feasible target temperature for whole body 
heating. To date, 24 systemic hyperthermia treatments 
have been delivered to nine patients in conjunction with 
oral DFMO administration under the guidance of a Phase 
I clinical trial for treatment of metastatic melanoma. Oral 
DFMO is administered every 8 hr for 4 days with hyper- 
thermia delivered on day 6. This course is repeated every 
2 weeks for 3-4 cycles with the planned dose escalation 
ranging from 0.5 gm/m2 QS hr - 5.0 gm/m2 QS hr. 
A critical element in achieving hyperthermic sensiti- 
zation by DFMO involves the actual depletion of endog- 
enous polyamines in the cells of interest (7,8, 16). Tissues 
or compartments which do not verifiably demonstrate 
depletions of putrescine and spermidine, would not be 
expected to display heat sensitization. We therefore per- 
form HPLC analysis of polyamine levels obtained from 
skin biopsies and buccal mucosa smears on patients being 
treated with DFMO as part of the Phase I protocol. Such 
evaluation will be critical in documenting that the oral 
administration of DFMO can successfully deplete endog- 
enous polyamine pools not only in GI mucosa, but in 
epidermis and subcutaneous tissue as well. Studies re- 
porting on both the technology involved in achieving 
whole body hyperthermia, and the complete Phase I tox- 
icity analysis are in progress. We continue aggressive ef- 
forts aimed at translating intriguing and reproducible 
findings from the cancer biology laboratory into the clinic 
in the treatment of human malignancy. 
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